http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20070452-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-08
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-03
filingDate 2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c9d792d842123db40220e68e591545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05a89f211fb372d1434de65a7388f047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa204866617884f8abfa0ceb438c329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667449229e0588cec0df3902fb628949
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_028f0fd2080fa5b033e84a916a15e5af
publicationDate 2008-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20070452-T3
titleOfInvention SULFONAMIDE DERIVATIVES INTENDED FOR THE TREATMENT OF DISEASE
abstract Compound of general formula (1): characterized in that the (CH 2) n C (= O) Q 1 group is in the meta or para position, R 1 and R 2 are independently selected from H and C 1 -C 4 alkyl, n is 0, 1 or 2, and Q1 is a group selected from:, and a group * -NR11-Q2-A, wherein p is 1 or 2, Q2 is C1-C4 alkylene, R11 is H or C1-C4 alkyl, and A is pyridyl, C3-C10 cycloalkyl, wherein said cycloalkyl is optionally bridged with one or more carbon atoms, tetrahydropyranyl, piperidinyl, optionally substituted with benzyl, tetrahydrothiopyranyl or a group wherein R3, R4, R5, R6 and R7 are the same or different and are selected from H, C1-C4 alkyl, OR5, SR9, halogen, CN, CF3, OCF3, COOR9, SO2NR9R10, CONR9R10, NR9R10, NHCOR10 and phenyl; wherein R 8 is C 1 -C 4 alkyl, R 8 and R 10 are the same or different and are selected from H or C 1 -C 4 alkyl, and * represents the point of attachment to the carbonyl group; or, if appropriate, pharmaceutically acceptable salts and (or) isomers, tautomers, solvates or isotopic variants thereof. The patent contains another 32 patent claims.
priorityDate 2004-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457797818

Total number of triples: 35.